share_log
Hi,
moomoo ID:0
Log Out
English
Back
  • English
  • 中文繁体
  • 中文简体

Equities Analysts Issue Forecasts for WELL Health Technologies Corp.'s FY2022 Earnings (TSE:WEL)

Defense World ·  08/18 13:31

WELL Health Technologies Corp. (TSE:WEL – Get Rating) – Research analysts at Desjardins upped their FY2022 EPS estimates for WELL Health Technologies in a research report issued on Monday, August 15th. Desjardins analyst J. Dubreuil now forecasts that the company will post earnings per share of $0.24 for the year, up from their prior forecast of $0.19. Desjardins also issued estimates for WELL Health Technologies' FY2023 earnings at $0.33 EPS.

Get WELL Health Technologies alerts:

WELL Health Technologies Price Performance

WELL Health Technologies (TSE:WEL – Get Rating) last issued its earnings results on Thursday, August 11th. The company reported C$0.04 earnings per share for the quarter, topping analysts' consensus estimates of C($0.03) by C$0.07. The firm had revenue of C$140.33 million for the quarter, compared to analyst estimates of C$129.38 million.

Further Reading

  • Which Semiconductor Stocks Are Ready For Big Price Moves?
  • Miners Advance On Earnings Despite Broader Economic Challenges
  • Lowe's Stands Out Amid Q2 Retail Reports
  • Agilent Technologies Proves Its Worth VS Illumina
  • Target's Results Cap Upside Potential For Retail Stocks

Receive News & Ratings for WELL Health Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WELL Health Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

This presentation is for informational and educational use only and is not a recommendation or endorsement of any particular investment or investment strategy. Investment information provided in this content is general in nature, strictly for illustrative purposes, and may not be appropriate for all investors. It is provided without respect to individual investors’ financial sophistication, financial situation, investment objectives, investing time horizon, or risk tolerance. You should consider the appropriateness of this information having regard to your relevant personal circumstances before making any investment decisions. Past investment performance does not indicate or guarantee future success. Returns will vary, and all investments carry risks, including loss of principal. Moomoo makes no representation or warranty as to its adequacy, completeness, accuracy or timeliness for any particular purpose of the above content.

Moomoo is a financial information and trading app offered by Moomoo Technologies Inc.
In the U.S., investment products and services available through the moomoo app are offered by Moomoo Financial Inc., a broker-dealer registered with the U.S. Securities and Exchange Commission (SEC) and a member of Financial Industry Regulatory Authority (FINRA)/Securities Investor Protection Corporation (SIPC).
In Singapore, investment products and services available through the moomoo app are offered through Moomoo Financial Singapore Pte. Ltd. regulated by the Monetary Authority of Singapore (MAS). Moomoo Financial Singapore Pte. Ltd. is a Capital Markets Services Licence (License No. CMS101000) holder with the Exempt Financial Adviser Status. This advertisement has not been reviewed by the Monetary Authority of Singapore.
In Australia, financial products and services available through the moomoo app are provided by Futu Securities (Australia) Ltd, an Australian Financial Services Licensee (AFSL No. 224663) regulated by the Australian Securities and Investment Commission (ASIC). Please read and understand our Financial Services Guide, Terms and Conditions, Privacy Policy and other disclosure documents which are available on our websites https://www.futuau.com and https://www.moomoo.com/au. Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd. and Futu Securities (Australia) Ltd are affiliated companies.